Celebrating Innovation and Achievement in the Life Sciences Industry
Examination Schools, University of Oxford
Thursday 7 November 2019
Thursday 7 November 2019
Welcome to
The OBN Awards 2019
The OBN Awards 2019
Join us and celebrate Innovation and Achievement in the Life Sciences Industry.
2019 marks the 11th Anniversary of the OBN Awards, that’s years of celebration and recognition for the leading lights of the Life Sciences industry.
We are delighted to announce that the awards will once again be taking place in the South and North Writing Schools of the impressive Examination Schools in Oxford. The Examination Schools were created to house the University of Oxford's examinations, and are still used today.
2019 marks the 11th Anniversary of the OBN Awards, that’s years of celebration and recognition for the leading lights of the Life Sciences industry.
We are delighted to announce that the awards will once again be taking place in the South and North Writing Schools of the impressive Examination Schools in Oxford. The Examination Schools were created to house the University of Oxford's examinations, and are still used today.
2019 Judging Panel
John Harris, CEO, OBN
John Chaddock, Vice President Neurology - Site Head, Ipsen Bioinnovation
Jonathan Rohll, Head of Business Information, OBN
Jon Bircher, Chief Commercial Officer, Cello Health
Bill Fleming, Chairman, OBN
Jutta Heix, International Advisor, Oslo Cancer Cluster
David Browning, Board Director, OBN
Peter Hamley, Global Head, External Innovation Drug Discovery, Sanofi
Carlos Pittol, Director, Clubb Capital
Robert Tansley, Investment Director, Cambridge Innovation Capital
Clare Sarvary-Fourrier, SVP, Clinical Operations – Europe, Precision for Medicine, Oncolgy & Rare Disease
Sarah Holland, Head of Licensing, Pharma and Biotech, Lonza
Jason Slingsby, Head of Business Development, Oxford Biomedica
John Chaddock, Vice President Neurology - Site Head, Ipsen Bioinnovation
Jonathan Rohll, Head of Business Information, OBN
Jon Bircher, Chief Commercial Officer, Cello Health
Bill Fleming, Chairman, OBN
Jutta Heix, International Advisor, Oslo Cancer Cluster
David Browning, Board Director, OBN
Peter Hamley, Global Head, External Innovation Drug Discovery, Sanofi
Carlos Pittol, Director, Clubb Capital
Robert Tansley, Investment Director, Cambridge Innovation Capital
Clare Sarvary-Fourrier, SVP, Clinical Operations – Europe, Precision for Medicine, Oncolgy & Rare Disease
Sarah Holland, Head of Licensing, Pharma and Biotech, Lonza
Jason Slingsby, Head of Business Development, Oxford Biomedica
Gold Sponsors
Bronze Sponsors
| Venue | Contact | |||
The Examination Schools 75 - 81 The High Street Oxford OX1 4BG |
General Enquiries E: events@obn.org.uk T: +44 (0)1235 420870 |
Organisers
OBN (UK) Ltd | 5F Park Square | Milton Park | Abingdon | Oxfordshire | OX14 4RR
© 2019, All Rights Reserved. OBN (UK) Ltd. Is A Limited Company Registered In England & Wales, Company No. 06618658. VAT No. 935 2567 09
